230 related articles for article (PubMed ID: 33506763)
1. Stem cell transplantation rescued a primary open-angle glaucoma mouse model.
Xiong S; Kumar A; Tian S; Taher EE; Yang E; Kinchington PR; Xia X; Du Y
Elife; 2021 Jan; 10():. PubMed ID: 33506763
[TBL] [Abstract][Full Text] [Related]
2. Restoration of Aqueous Humor Outflow Following Transplantation of iPSC-Derived Trabecular Meshwork Cells in a Transgenic Mouse Model of Glaucoma.
Zhu W; Jain A; Gramlich OW; Tucker BA; Sheffield VC; Kuehn MH
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2054-2062. PubMed ID: 28384726
[TBL] [Abstract][Full Text] [Related]
3. Expression of Mutant Myocilin Induces Abnormal Intracellular Accumulation of Selected Extracellular Matrix Proteins in the Trabecular Meshwork.
Kasetti RB; Phan TN; Millar JC; Zode GS
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6058-6069. PubMed ID: 27820874
[TBL] [Abstract][Full Text] [Related]
4. Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma.
Zode GS; Bugge KE; Mohan K; Grozdanic SD; Peters JC; Koehn DR; Anderson MG; Kardon RH; Stone EM; Sheffield VC
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1557-65. PubMed ID: 22328638
[TBL] [Abstract][Full Text] [Related]
5. Ex-vivo cultured human corneoscleral segment model to study the effects of glaucoma factors on trabecular meshwork.
Kasetti RB; Patel PD; Maddineni P; Zode GS
PLoS One; 2020; 15(6):e0232111. PubMed ID: 32579557
[TBL] [Abstract][Full Text] [Related]
6. Mutated myocilin and heterozygous Sod2 deficiency act synergistically in a mouse model of open-angle glaucoma.
Joe MK; Nakaya N; Abu-Asab M; Tomarev SI
Hum Mol Genet; 2015 Jun; 24(12):3322-34. PubMed ID: 25740847
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma.
Patil SV; Kaipa BR; Ranshing S; Sundaresan Y; Millar JC; Nagarajan B; Kiehlbauch C; Zhang Q; Jain A; Searby CC; Scheetz TE; Clark AF; Sheffield VC; Zode GS
Sci Rep; 2024 Mar; 14(1):6958. PubMed ID: 38521856
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of iPSC-derived TM cells rescues glaucoma phenotypes in vivo.
Zhu W; Gramlich OW; Laboissonniere L; Jain A; Sheffield VC; Trimarchi JM; Tucker BA; Kuehn MH
Proc Natl Acad Sci U S A; 2016 Jun; 113(25):E3492-500. PubMed ID: 27274060
[TBL] [Abstract][Full Text] [Related]
9. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma.
Zode GS; Kuehn MH; Nishimura DY; Searby CC; Mohan K; Grozdanic SD; Bugge K; Anderson MG; Clark AF; Stone EM; Sheffield VC
J Clin Invest; 2011 Sep; 121(9):3542-53. PubMed ID: 21821918
[TBL] [Abstract][Full Text] [Related]
10. α5β1 Integrin Promotes Anchoring and Integration of Transplanted Stem Cells to the Trabecular Meshwork in the Eye for Regeneration.
Xiong S; Xu Y; Wang Y; Kumar A; Peters DM; Du Y
Stem Cells Dev; 2020 Mar; 29(5):290-300. PubMed ID: 31854234
[TBL] [Abstract][Full Text] [Related]
11. Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma.
Stothert AR; Fontaine SN; Sabbagh JJ; Dickey CA
Exp Eye Res; 2016 Mar; 144():38-45. PubMed ID: 26302411
[TBL] [Abstract][Full Text] [Related]
12. Myocilin in the trabecular meshwork of eyes with primary open-angle glaucoma.
Konz DD; Flügel-Koch C; Ohlmann A; Tamm ER
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1643-9. PubMed ID: 19662433
[TBL] [Abstract][Full Text] [Related]
13. Aggregated myocilin induces russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma.
Yam GH; Gaplovska-Kysela K; Zuber C; Roth J
Am J Pathol; 2007 Jan; 170(1):100-9. PubMed ID: 17200186
[TBL] [Abstract][Full Text] [Related]
14. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor.
Jacobson N; Andrews M; Shepard AR; Nishimura D; Searby C; Fingert JH; Hageman G; Mullins R; Davidson BL; Kwon YH; Alward WL; Stone EM; Clark AF; Sheffield VC
Hum Mol Genet; 2001 Jan; 10(2):117-25. PubMed ID: 11152659
[TBL] [Abstract][Full Text] [Related]
15. Characterizing differences between MSCs and TM cells: Toward autologous stem cell therapies for the glaucomatous trabecular meshwork.
Snider EJ; Vannatta RT; Schildmeyer L; Stamer WD; Ethier CR
J Tissue Eng Regen Med; 2018 Mar; 12(3):695-704. PubMed ID: 28556530
[TBL] [Abstract][Full Text] [Related]
16. Expression of myocilin mutants sensitizes cells to oxidative stress-induced apoptosis: implication for glaucoma pathogenesis.
Joe MK; Tomarev SI
Am J Pathol; 2010 Jun; 176(6):2880-90. PubMed ID: 20382707
[TBL] [Abstract][Full Text] [Related]
17. Autophagy stimulation reduces ocular hypertension in a murine glaucoma model via autophagic degradation of mutant myocilin.
Kasetti RB; Maddineni P; Kiehlbauch C; Patil S; Searby CC; Levine B; Sheffield VC; Zode GS
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33539326
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of adult human trabecular meshwork stem cells.
Sundaresan Y; Ramasamy KS; Veerappan M; Chidambaranathan GP
Exp Cell Res; 2021 Aug; 405(2):112709. PubMed ID: 34174318
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator attenuates outflow facility reduction in mouse model of juvenile open angle glaucoma.
Gindina S; Hu Y; Barron AO; Qureshi Z; Danias J
Exp Eye Res; 2020 Oct; 199():108179. PubMed ID: 32739292
[TBL] [Abstract][Full Text] [Related]
20. Cell-Based Therapies for Trabecular Meshwork Regeneration to Treat Glaucoma.
Mallick S; Sharma M; Kumar A; Du Y
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
